Deroy & Devereaux Private Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Sell |
1,503
-11
| -0.7% | -$11.2K | 0.08% | 107 |
|
|
2026
Q1 | $1.39M | Sell |
1,514
-700
| -32% | -$710K | 0.07% | 109 |
|
|
2025
Q4 | $2.38M | Sell |
2,214
-6
| -0.3% | -$5.74K | 0.12% | 98 |
|
|
2025
Q3 | $1.69M | Hold |
2,220
| – | – | 0.08% | 105 |
|
|
2025
Q2 | $1.73M | Sell |
2,220
-444
| -17% | -$345K | 0.09% | 100 |
|
|
2025
Q1 | $2.2M | Buy |
2,664
+45
| +2% | +$37.4K | 0.13% | 92 |
|
|
2024
Q4 | $2.02M | Buy |
2,619
+8
| +0.3% | +$6.62K | 0.12% | 94 |
|
|
2024
Q3 | $2.31M | Hold |
2,611
| – | – | 0.13% | 94 |
|
|
2024
Q2 | $2.36M | Sell |
2,611
-148
| -5% | -$118K | 0.15% | 93 |
|
|
2024
Q1 | $2.15M | Hold |
2,759
| – | – | 0.13% | 94 |
|
|
2023
Q4 | $1.61M | Sell |
2,759
-642
| -19% | -$375K | 0.11% | 97 |
|
|
2023
Q3 | $1.83M | Hold |
3,401
| – | – | 0.13% | 95 |
|
|
2023
Q2 | $1.59M | Buy |
3,401
+1,198
| +54% | +$502K | 0.11% | 96 |
|
|
2023
Q1 | $757K | Hold |
2,203
| – | – | 0.06% | 97 |
|
|
2022
Q4 | $806K | Sell |
2,203
-70
| -3% | -$24.8K | 0.06% | 96 |
|
|
2022
Q3 | $735K | Hold |
2,273
| – | – | 0.06% | 96 |
|
|
2022
Q2 | $737K | Hold |
2,273
| – | – | 0.06% | 97 |
|
|
2022
Q1 | $651K | Hold |
2,273
| – | – | 0.05% | 112 |
|
|
2021
Q4 | $628K | Hold |
2,273
| – | – | 0.05% | 109 |
|
|
2021
Q3 | $525K | Hold |
2,273
| – | – | 0.04% | 110 |
|
|
2021
Q2 | $522K | Sell |
2,273
-90
| -4% | -$18.1K | 0.04% | 114 |
|
|
2021
Q1 | $441K | Buy |
2,363
+90
| +4% | +$17.6K | 0.03% | 120 |
|
|
2020
Q4 | $384K | Hold |
2,273
| – | – | 0.03% | 120 |
|
|
2020
Q3 | $336K | Hold |
2,273
| – | – | 0.04% | 123 |
|
|
2020
Q2 | $373K | Hold |
2,273
| – | – | 0.04% | 113 |
|
|
2020
Q1 | $315K | Hold |
2,273
| – | – | 0.04% | 115 |
|
|
2019
Q4 | $299K | Hold |
2,273
| – | – | 0.03% | 112 |
|
|
2019
Q3 | $254K | Hold |
2,273
| – | – | 0.02% | 124 |
|
|
2019
Q2 | $252K | Hold |
2,273
| – | – | 0.02% | 126 |
|
|
2019
Q1 | $295K | Sell |
2,273
-27
| -1% | -$3.28K | 0.03% | 116 |
|
|
2018
Q4 | $266K | Hold |
2,300
| – | – | 0.03% | 130 |
|
|
2018
Q3 | $247K | Buy |
+2,300
| New | +$230K | 0.02% | 156 |
|
|
2016
Q1 | – | Sell |
-2,721
| Closed | -$229K | – | 166 |
|
|
2015
Q4 | $229K | Hold |
2,721
| – | – | 0.03% | 142 |
|
|
2015
Q3 | $228K | Buy |
2,721
+3
| +0.1% | +$253 | 0.03% | 142 |
|
|
2015
Q2 | $227K | Buy |
+2,718
| New | +$207K | 0.03% | 144 |
|
Other funds holding LLY
Deroy & Devereaux Private Investment Counsel's LLY Position: Q2 2026 in Review
Deroy & Devereaux Private Investment Counsel reduced its Eli Lilly (LLY) stake by 0.73% in Q2 2026, selling an estimated $11.2K and leaving 1,503 shares worth $1.8M. The position accounts for 0.08% of the portfolio, ranked #107.
Deroy & Devereaux Private Investment Counsel first reported a position in LLY in Q2 2015 and has held it in 35 quarters since. The position peaked at $2.38M in Q4 2025. 3,242 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Deroy & Devereaux Private Investment Counsel held 1,503 shares of Eli Lilly worth $1.8M as of Q2 2026.
- Deroy & Devereaux Private Investment Counsel sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
- Eli Lilly made up 0.08% of Deroy & Devereaux Private Investment Counsel's portfolio in Q2 2026, its #107 holding.
- Deroy & Devereaux Private Investment Counsel first reported a position in Eli Lilly in Q2 2015 and has held it in 35 quarters since.
- Deroy & Devereaux Private Investment Counsel's Eli Lilly position peaked at $2.38M in Q4 2025.
- 3,242 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.